Literature DB >> 30391530

Incidence and Outcomes of Intraoperative Descemet Membrane Perforations During Deep Anterior Lamellar Keratoplasty.

Olivia S Huang1, Hla M Htoon2, Amy M Chan3, Donald Tan4, Jodhbir S Mehta5.   

Abstract

PURPOSE: To report the incidence and outcomes of intraoperative Descemet membrane (DM) perforations during deep anterior lamellar keratoplasty (DALK).
DESIGN: Retrospective, consecutive, interventional case series.
METHODS: A retrospective audit of all DALK cases performed from 2004 to 2015 in a tertiary center, with and without intraoperative DM perforations. We excluded cases with preexisting corneal perforations before surgery.
RESULTS: There were a total of 540 eyes, of which 101 (18.7%) had intraoperative DM perforations. These included 79 eyes (78.2%) with microperforations and 15 eyes (14.9%) with macroperforation. The most common steps at which DM perforation occurred intraoperatively were during deep lamellar dissection (32 cases; 31.7%), air injection (27 cases; 26.7%), and suturing (21 cases; 20.8%). Management of the DM perforations included a combination of intracameral air tamponade (49 cases; 48.5%), stromal patching (10 cases; 9.9%), fibrin glue (8 cases; 7.9%), and suturing of the defect (1 case; 1.1%). There were 2 eyes (2/540; 0.37%) that were converted to penetrating keratoplasty (PK). There were no significant differences in the postoperative unaided or best-corrected visual acuity, or in the numbers of patients with postoperative graft failure, graft rejection, or subsequent surgery at postoperative years 1 and 3.
CONCLUSIONS: DALK cases with DM perforations intraoperatively are often able to be managed without conversion to PK. Cases with DM perforations intraoperatively have equivalent visual acuity outcomes compared to those without DM perforations, and did not have any increased risk of graft failure, rejection, or subsequent surgery at postoperative years 1 and 3.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30391530     DOI: 10.1016/j.ajo.2018.10.026

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  7 in total

1.  Use of Fibrin Glue in the Management of Descemet Membrane Perforation during Deep Anterior Lamellar Keratoplasty.

Authors:  Saad S Alharbi; Ahmad Alameer
Journal:  Middle East Afr J Ophthalmol       Date:  2019-09-30

2.  Stromal Patch with fibrin glue as a novel surgical technique to seal peripheral Descemet's membrane perforations in deep anterior lamellar keratoplasty.

Authors:  Reza Ghaffari; Hamed Ghassemi; Golshan Latifi; Mahmood Jabbarvand; Alireza Zamzam; Hassan Hashemi
Journal:  Int Ophthalmol       Date:  2019-01-17       Impact factor: 2.031

3.  Clinical comparison of manual and laser-cut corneal tunnel for intrastromal air injection in femtosecond laser-assisted deep anterior lamellar keratoplasty (DALK).

Authors:  Asaf Achiron; Boris Knyazer; Boris E Malyugin; Alexandra Belodedova; Olga Antonova; Aslan Gelyastanov; Raimo Tuuminen; Eliya Levinger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-07-28       Impact factor: 3.535

4.  Deep anterior lamellar keratoplasty for keratoconus: Elements for success.

Authors:  Marco Pellegrini; Angeli Christy Yu; Massimo Busin
Journal:  Saudi J Ophthalmol       Date:  2022-07-11

5.  Deep Anterior Lamellar Keratoplasty with Large Descemet's Membrane Perforation: Should We Stop Conversion to Penetrating Keratoplasty?

Authors:  Mohamed Bahgat Goweida; Shahira Mahmoud; Mohamed Sobhy; Christopher Liu
Journal:  J Curr Ophthalmol       Date:  2021-07-05

6.  Re-Endothelialization of Bare Stroma after Descemet's Detachment due to Macroperforation during Deep Anterior Lamellar Keratoplasty.

Authors:  Zahra Ashena; Mayank A Nanavaty
Journal:  J Curr Ophthalmol       Date:  2020-12-12

7.  Large-diameter Deep Anterior Lamel-lar Keratoplasty: An Alternative Treatment for Mooren Ulcer.

Authors:  Yang Kyung Cho; Sun Young Lee; Ui Ju Cho; Balamurali K Ambati
Journal:  Korean J Ophthalmol       Date:  2020-10-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.